T1	DISO 676 680	CPNM
#1	AnnotatorNotes T1	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T2	DISO 970 980	mutaciones
#2	AnnotatorNotes T2	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T3	PROC 67 94	tratamientos de combinación
T4	DISO 111 142	cáncer de pulmón no microcítico
#3	AnnotatorNotes T4	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T5	PROC 174 195	Evaluación en fase II
T6	PROC 223 250	tratamientos de combinación
T7	PROC 257 281	estudio inmunooncológico
T8	DISO 297 328	cáncer de pulmón no microcítico
#4	AnnotatorNotes T8	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T9	DISO 471 502	Cáncer de pulmón no microcítico
#5	AnnotatorNotes T9	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T10	DISO 538 569	Cáncer de pulmón no microcítico
#6	AnnotatorNotes T10	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T11	DISO 580 584	CPNM
#7	AnnotatorNotes T11	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T12	PROC 620 629	protocolo
#8	AnnotatorNotes T12	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T13	DISO 643 674	Cáncer de pulmón no microcítico
#9	AnnotatorNotes T13	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T14	DISO 863 881	enfermedad medible
#10	AnnotatorNotes T14	C1513041; Measurable Disease; Disease or Syndrome
T15	PROC 789 818	tratamiento con quimioterapia
T16	PROC 825 838	inmunoterapia
#11	AnnotatorNotes T16	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T17	DISO 852 858	lesión
#12	AnnotatorNotes T17	C0221198; Lesion; Finding
T18	PROC 916 925	protocolo
#13	AnnotatorNotes T18	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T19	PROC 1000 1011	tratamiento
#14	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	DISO 1092 1133	metástasis en el sistema nervioso central
T21	ANAT 1109 1133	sistema nervioso central
#15	AnnotatorNotes T21	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T22	PROC 1157 1168	tratamiento
#16	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 1204 1218	oxigenoterapia
#17	AnnotatorNotes T23	C0184633; Oxygen Therapy Care; Therapeutic or Preventive Procedure
T24	DISO 1241 1270	enfermedades autoinmunitarias
#18	AnnotatorNotes T24	C0004364; Autoimmune Diseases; Disease or Syndrome
T25	ANAT 121 127	pulmón
#19	AnnotatorNotes T25	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T26	ANAT 131 142	microcítico
#20	AnnotatorNotes T26	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T27	ANAT 307 313	pulmón
#21	AnnotatorNotes T27	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T28	ANAT 317 328	microcítico
#22	AnnotatorNotes T28	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T29	ANAT 481 487	pulmón
#23	AnnotatorNotes T29	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T30	ANAT 491 502	microcítico
#24	AnnotatorNotes T30	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T31	ANAT 548 554	pulmón
#25	AnnotatorNotes T31	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T32	ANAT 558 569	microcítico
#26	AnnotatorNotes T32	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T33	ANAT 653 659	pulmón
#27	AnnotatorNotes T33	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T34	ANAT 663 674	microcítico
#28	AnnotatorNotes T34	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T35	Date 13 17	2016
T36	LIVB 98 106	personas
#29	AnnotatorNotes T36	C0027361; Persons; Population Group
T37	Neg_cue 128 130	no
T38	LIVB 285 292	sujetos
#30	AnnotatorNotes T38	C0681850; Study Subject; Group
T39	Neg_cue 314 316	no
T40	Neg_cue 488 490	no
T41	Neg_cue 555 557	no
T42	Neg_cue 660 662	no
T44	Duration 757 773	al menos 3 meses
T45	LIVB 943 952	pacientes
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Neg_cue 1073 1075	ni
T50	LIVB 1180 1189	Pacientes
#32	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Frequency 1219 1225	diaria
T52	LIVB 1228 1236	Personas
#33	AnnotatorNotes T52	C0027361; Persons; Population Group
T43	PROC 693 709	Estado funcional
#34	AnnotatorNotes T43	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T47	Date 380 391	27-Jul-2016
T48	Date 442 446	2016
T49	CONC 736 753	Esperanza de vida
A1	Assertion T26 Negated
A2	Assertion T28 Negated
A3	Assertion T30 Negated
A4	Assertion T32 Negated
A5	Assertion T34 Negated
A6	Assertion T20 Negated
A7	Status T15 History_of
A8	Status T16 History_of
#35	AnnotatorNotes T5	C0282460; Phase 2 Clinical Trials; Research Activity
#36	AnnotatorNotes T3	C0013218; Combination Drug Therapy; Therapeutic or Preventive Procedure (?)
#37	AnnotatorNotes T6	C0013218; Combination Drug Therapy; Therapeutic or Preventive Procedure (?)
#39	AnnotatorNotes T15	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure + C3665472; Chemotherapy; Therapeutic or Preventive Procedure
#40	AnnotatorNotes T20	C0686377; CNS metastases; Neoplastic Process
R1	Experiences Arg1:T36 Arg2:T3	
R2	Experiences Arg1:T36 Arg2:T4	
R3	Location_of Arg1:T25 Arg2:T4	
R4	Negation Arg1:T37 Arg2:T26	
T53	Quantifier_or_Qualifier 143 151	avanzado
R5	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T53	
R7	Experiences Arg1:T38 Arg2:T6	
R8	Experiences Arg1:T38 Arg2:T8	
R9	Negation Arg1:T39 Arg2:T28	
R10	Location_of Arg1:T27 Arg2:T8	
T54	Quantifier_or_Qualifier 329 337	avanzado
R11	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T54	
R12	Negation Arg1:T40 Arg2:T30	
R13	Location_of Arg1:T29 Arg2:T9	
R14	Location_of Arg1:T31 Arg2:T10	
R15	Negation Arg1:T41 Arg2:T32	
T55	Quantifier_or_Qualifier 570 578	avanzado
R16	Location_of Arg1:T31 Arg2:T11	
T56	Quantifier_or_Qualifier 503 511	avanzado
R17	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T56	
R18	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T55	
R19	Negation Arg1:T42 Arg2:T34	
R20	Location_of Arg1:T33 Arg2:T13	
R21	Location_of Arg1:T33 Arg2:T1	
T57	Quantifier_or_Qualifier 682 690	avanzado
R22	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T57	
T58	CONC 726 730	ECOG
#41	AnnotatorNotes T58	C1520224; ECOG performance status; Intellectual Product
R23	Used_for Arg1:T58 Arg2:T43	
T59	Result_or_Value 731 733	≤1
R24	Has_Result_or_Value Arg1:T58 Arg2:T59	
R25	Has_Duration_or_Interval Arg1:T49 Arg2:T44	
#42	AnnotatorNotes T49	C0023671; Life Expectancy; Group Attribute
R26	After Arg1:T49 Arg2:T15	
R27	After Arg1:T49 Arg2:T16	
T60	Quantifier_or_Qualifier 841 851	Al menos 1
R28	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T60	
R29	Overlap Arg1:T17 Arg2:T14	
R30	Experiences Arg1:T45 Arg2:T2	
R31	Experiences Arg1:T45 Arg2:T19	
T62	CONC 1035 1044	inclusión
#44	AnnotatorNotes T62	C1512693; Inclusion; Qualitative Concept
R33	Before Arg1:T19 Arg2:T62	
R34	Negation Arg1:T46 Arg2:T20	
R35	Location_of Arg1:T21 Arg2:T20	
R36	Experiences Arg1:T50 Arg2:T23	
R37	Has_Frequency Arg1:T23 Arg2:T51	
R38	Experiences Arg1:T52 Arg2:T24	
R39	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T57	
R40	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T55	
#38	AnnotatorNotes T53	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
#43	AnnotatorNotes T54	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
#45	AnnotatorNotes T56	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
#46	AnnotatorNotes T55	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
#47	AnnotatorNotes T57	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
A9	Experiencer T52 Patient
A10	Experiencer T50 Patient
A11	Experiencer T45 Patient
A12	Status T19 Future
A13	Assertion T22 Hypothetical
A14	Experiencer T36 Patient
A15	Experiencer T38 Patient
A16	Status T62 Future
